Drug profile · INN
cefuroxime axetil
CEFTIN
cefuroxime axetil (CEFTIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — cefuroxime axetil
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
cefuroxime axetil (CEFTIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cefuroxime axetil?
cefuroxime axetil (CEFTIN) is a bacterial penicillin-binding protein inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for cefuroxime axetil?
CEFTIN is a marketed brand name for cefuroxime axetil. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefuroxime axetil?
cefuroxime axetil has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.